Reprinted with the kind permission of Celeste Cooper
The FM/a® Test is making a huge impact on the way fibromyalgia is diagnosed, and now it is being used for very important research.
In November of 2017, I wrote about the exciting research that focuses on finding the cause and developing a treatment for fibromyalgia. (1) February of this year, I reported that genetic studies on fibromyalgia are well underway – with the assistance of the University of California, UCLA, and University of Illinois at Chicago. (2) In April of 2017, “Breaking News” included information relative to this announcement. (3)
Under contract with researchers from both UCLA and the University of Illinois College of Medicine Chicago, Campaign 250 will conduct Whole-Exome genetic testing on up to 250,000 patients who have received a positive FM/a® fibromyalgia diagnosis…
Based upon the findings of this testing and once treatment protocols have received regulatory and institutional approvals, FM/a® Test positive patients will be invited to participate in a fibromyalgia-specific vaccine clinical trial to reverse the biology of fibromyalgia…
I am excited to report that the long-term reduction in hyperglycemia in advanced type 1 diabetes using BCG vaccine found that after year 3, BCG lowered hemoglobin A1c (a blood test to monitor blood sugars over a period of time) to near normal levels for the next 5 years. That is a significant result. This same vaccine was reported in the above “Breaking News” statement. This is important because this old vaccine for tuberculosis now shows promise as treatment for numerous inflammatory and autoimmune diseases.
BCG = attenuated Mycobacterium bovis Bacillus Calmette Guérin (BCG) strain.
Professor Denise Faustman, specialist in immunology who is affiliated with Harvard Medical School and Massachusetts General Hospital, was a lead researcher in the vaccine study for diabetes and she will lead the vaccine study for fibromyalgia. The only qualification to participate in this exciting research is to have tested positive with the FM/a Test.
“FM/a® is a multi-biomarker-based test which concerns immune system white blood chemokine and cytokine patterns. Patients with fibromyalgia have a significantly dysregulated pattern regarding these proteins.”
Subscribe to the World's Most Popular Newsletter (it's free!)
I am a participant in the genome study and will be enrolled in the vaccine trial.
Will you join me?
The blood test is now covered by most insurance, including CHAMPVA and Medicare.
- The FM/a® Blood Test and Participation in Fibromyalgia Vaccine Study
- Update: Fibromyalgia FM/a Blood Test and EpicGenetics Landmark Clinical Research Efforts
- EpicGenetics Announces Major Clinical Study to Locate Genetic Markers Unique to People with Fibromyalgia and Explore New Treatment Approaches
- Peer-reviewed Medical Publications
- Researchers Seek to Find Cause of Fibromyalgia via Genetic Testing
- Learn More, including taking the first steps, information about the FM/a® Test and Frequently Asked Questions.
Celeste Cooper, RN
Think adversity? See opportunity!
Celeste Cooper, RN, is a frequent contributor to ProHealth. She is an advocate, writer and published author, and a person living with chronic pain. Celeste is lead author of Integrative Therapies for Fibromyalgia, Chronic Fatigue Syndrome, and Myofascial Pain and Broken Body, Wounded Spirit, and Balancing the See Saw of Chronic Pain (a four book series). She spends her time enjoying her family and the rewards she receives from interacting with nature through her writing and photography. You can learn more about Celeste’s writing, advocacy work, helpful tips, and social network connections at CelesteCooper.com.